Close Menu

biomarker discovery

Using a network-based meta-analysis, a duo from Rosalind Franklin University of Medicine and Science homed in on HNF4A and PTBP1 mRNAs as Parkinson's disease biomarkers.

NEW YORK (GenomeWeb) – VolitionRx today announced a collaboration with the University of Oxford on a clinical study to develop biomarkers for the diagnosis of endometriosis using the firm's Nucleosomics platform.

NEW YORK (GenomeWeb) – Advanced Cell Dx today announced Edinburgh, Scotland-based CRO Aquila-Histoplex as the first accredited RNAscope Certified Service Provider in Europe.

NEW YORK (GenomeWeb) — Biomarker development firm Denovo Biopharma has acquired the late-stage oncology drug enzastaurin from Eli Lilly and Company, and plans to use its genotyping platform to uncover a genomic marker or markers that can support new clinical trials advancing the drug for a genomi

NEW YORK (GenomeWeb) – Scientists at Nova Southeastern University's Institute for Neuro-Immune Medicine will use a $2 million grant from the National Institute of Neurological Disorders and Stroke to study complex biomarkers of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in men, N

NEW YORK (GenomeWeb) – Biocartis announced today that it has raised €64.5 million ($84 million) in a round of private financing.

NEW YORK (GenomeWeb) – Cancer Genetics today said that it will collaborate with a researcher at Keck Medicine of the University of Southern California to identify genomic markers of diffuse large B-cell lymphoma.

NEW YORK (GenomeWeb) – The National Institute of Neurological Disorders and Stroke will support research projects to discover and use biomarkers for Parkinson's disease, NINDS said in a new funding announcement on Monday.

NEW YORK (GenomeWeb) – Protea Biosciences Group today said that it has signed an agreement to collaborate with the University of Southampton to identify biomarkers that may indicate a risk of developing Alzheimer's disease.

NEW YORK (GenomeWeb) – Bioinformatics firm Berg today said that it will collaborate with researchers at the University of South Carolina in a search for lupus biomarkers.

Pages

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.